Safeguarding the COVID-19 Vaccine: A Case Study in Global Supply Chain Security

In the race to create a Covid-19 vaccine by collaborating across the industry, pharmaceutical companies have exposed more threat surfaces than existed before the pandemic. By combining multiple cybersecurity best practices and strategies, pharmaceutical companies stand a better chance of protecting their valuable IP and vaccines. This publication presents are ten ways the pharmaceutical industry needs to protect the Covid-19 vaccine supply chain. By closing the cybersecurity gaps in vaccine supply chains, the world’s nations can find new, leaner, more efficient processes to distribute vaccines and protect their citizens. By combining multiple cybersecurity tactics, techniques and procedures, the vaccine supply chain stands to improve and be more secure from threats.

Read the Full Whitepaper

Safeguarding-the-COVID-19-Vaccine-5.pdf

Download PDF • 432KB